Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.
Lin JS, Mamlouk O, Selamet U, Tchakarov A, Glass WF, Sheth RA, Layman RM, Dadu R, Abdelwahab N, Abdelrahim M, Diab A, Yee C, Abudayyeh A.
Lin JS, et al. Among authors: sheth ra.
Oncoimmunology. 2021 Feb 2;10(1):1877415. doi: 10.1080/2162402X.2021.1877415.
Oncoimmunology. 2021.
PMID: 33643693
Free PMC article.